|
biomedicina slovenica |
"Cetuximab" : 39
-
Zupančič Tina; Zakotnik Branko; Grašič-Kuhar Cvetka
Outcome of patients with recurrent/metastatic squamous cell head and neck cancer treated with platinum-based chemotherapy with or without cetuximab in real-world practice
2021 ►
-
Gaiser Maria R.; Lorenzen Sylvie; Merx Kirsten; Trojan Jörg; Ocvirk Janja; Ettrich Thomas J.; Al-Batran Salah Eddin; Schulz Holger; Feustel Hans-Peter; Hofheinz Ralf-Dieter
Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women
2018 ►
-
Gaiser Maria R.; Lorenzen Sylvie; Merx Kirsten; Trojan Jörg; Ocvirk Janja; Ettrich Thomas J.; Al-Batran Salah Eddin; Schulz Holger; Homann Nils; Feustel Hans-Peter
Evaluation of EGFR inhibitor-mediated acneiform skin toxicity within the double-blind randomized EVITA trial
2019 ►
-
Strojan Primož; Zakotnik Branko; Žumer Barbara; Karner Katarina Barbara; Dremelj Marta; Jančar Boris; Jereb Simona; Grašič-Kuhar Cvetka
Skin reaction to cetuximab as a criterion for treatment selection in head and neck cancer
2018 ►
-
Grašič-Kuhar Cvetka; Strojan Primož; Zadnik Vesna; Zakotnik Branko
Importance of magnesium sulfate supplementation in the prevention of hypomagnesemia and hypocalcemia during chemoradiation in head and neck cancer
2018 ►
-
Hofheinz Ralf-Dieter; Lorenzen Sylvie; Trojan Jörg; Ocvirk Janja; Ettrich Thomas J.; Al-Batran Salah Eddin; Schulz Holger; Homann Nils; Feustel H. P.; Schatz Marlene
EVITA
2018 ►
-
Saba Nabil F.; Mody Mayur D.; Tan Elaine S.; Gill Harpaul S.; Rinaldo Alessandra; Takes Robert P.; Strojan Primož; Hartl Dana M.; Vermorken Jan B.; Haigentz Missak; Ferlito Alfio
Toxicities of systemic agents in squamous cell carcinoma of the head and neck (SCCHN)
2017 ►
-
Hofheinz Ralf-Dieter; Deplanque Gaël; Komatsu Yoshito; Kobayashi Yoshimitsu; Ocvirk Janja; Racca Patrizia; Guenther Silke; Zhang Jun; Lacouture Mario E.; Jato Eminah
Recommendations for the prophylactic management of skin reactions induced by epidermal growth factor receptor inhibitors in patients with solid tumors
2016 ►
-
Mesti Tanja; Ebert Moltara Maja
Kolorektalni rak
2009 ►
-
Ciuleanu Tudor; Scheithauer W.; Kurteva G.; Ocvirk Janja; Koza I.; Papamichael D.; Wenczl M.; Brodowicz Thomas; Beslija Semir; Zielinski Christoph C.
A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC)
2008 ►
-
Ciuleanu Tudor; Ocvirk Janja
A randomized, open-label CECOG phase II study evaluating the efficacy and safety of FOLFOX6 + cetuximab versus FOLFIRI + cetuximab as first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC)
2008 ►
-
Hu-Lieskovan Siwen; Velenik Vaneja
Use of EGF a+61G and TS-5'UTR 2R/3R polymorphisms to predict complete pathologic response in locally advanced rectal cancer patients undergoing preoperative cetuximab-based chemoradiation followed by surgery
2010 ►
-
Vallbohmer D.; Velenik Vaneja
Biomarkers for cetuximab-based neoadjuvant radiochemotherapy in advanced rectal cancer
2010 ►
-
Ocvirk Janja; Reberšek Martina
Treatment of cetuximab-associated cutaneous side effects using topical aplication [!] oh [!] vitamin K1 cream
2009 ►
-
Koza I.; Ocvirk Janja
Correlation of KRAS status with clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated first-line with FOLFOX6 + cetuximab (FX+C) or FOLFIRI + cetuximab (FF+C)
2009 ►
-
Velenik Vaneja; Ocvirk Janja; Oblak Irena; Anderluh Franc
Neoadjuvant cetuximab, capecitabine, and radiotherapy (RT) in locally advanced resectable rectal cancer
2009 ►
-
Velenik Vaneja; Ocvirk Janja; Oblak Irena; Anderluh Franc
Phase II XERT trial: neoadjuvant cetuximab, capecitabine and radiotherapy (RT) in locally advanced resectable rectal cancer
2009 ►
-
Ciuleanu Tudor; Ocvirk Janja
A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer
2007 ►
-
Velenik Vaneja; Ocvirk Janja; Oblak Irena; Anderluh Franc
Preoperative radiotherapy, capecitabine and cetuximab for locally advanced rectal cancer
2011 ►
-
Velenik Vaneja; Ocvirk Janja; Oblak Irena; Anderluh Franc
Five-year results of the XERT phase II trial
2014 ►
-
Strojan Primož; Žumer Barbara; Karner Katarina Barbara; Grašič-Kuhar Cvetka; Jančar Boris; Fajdiga Igor; Zakotnik Branko
Concomitant cisplatin (CP)/cetuximab (CMb) chemoradioctherapy (ChT-RT) with induction TPF ChT in stage IV inoperable squamous cell carcinoma of the head and neck (SCC-HN)
2012 ►
-
Strojan Primož; Grašič-Kuhar Cvetka; Žumer Barbara; Kadivec Maksimiljan; Karner Katarina Barbara; Fajdiga Igor; Jančar Boris; Gale Nina; Poljak Mario; Kocjan Boštjan; Zakotnik Branko
TPF induction chemotherapy and concomitant irradiation with cisplatin and cetuximab in unresectable squamous cell carcinoma of the head and neck
2014 ►
-
Strojan Primož; Zakotnik Branko; Žumer Barbara; Grašič-Kuhar Cvetka; Karner Katarina Barbara; Fajdiga Igor; Jančar Boris
Uvodna kemoterapija in sočasna radiokemoimunoterapija s cisplatinom in cetuksimabom pri neoperabilnem raku glave in vratu
[Induction chemotherapy and concomitant radiochemoimmunotherapy with cisplatin and cetuximab in inoperable cancer of head and neck]
2012 ►
-
Ocvirk Janja; Boc Marko; Reberšek Martina; Mesti Tanja; Ebert Maja
Efficacy and safety of XELIRI plus cetuximab versus XELOX plus cetuximab in first-line treatment of metastatic colorectal cancer (mCRC)
2011 ►
-
Ocvirk Janja; Reberšek Martina; Boc Marko; Mesti Tanja; Ebert Maja
Prophylactic use of K1 cream for reducing skin toxicity during cetuximab treatment in patients with metastatic colorectal cancer (mCRC)
2010 ►
-
Ocvirk Janja; Reberšek Martina
Managing cutaneous side effects with K1 vitamine creme reduces cutaneous toxicities induced by cetuximab
2008 ►
-
Ocvirk Janja; Heeger Steffen; McCloud Philip; Hofheinz Ralf-Dieter
#A #review of the treatment options for skin rash induced by EGFR-targeted therapies
2013 ►
-
Ocvirk Janja; Ebert Maja; Mesti Tanja; Boc Marko; Reberšek Martina
#The #prophylactic use of K1 cream for reduction of skin toxicity during the cetuximab treatment
2012 ►
-
Grašič-Kuhar Cvetka; Zakotnik Branko; Žumer Barbara; Karner Katarina Barbara; Jančar Boris; Strojan Primož
Induction TPF chemotherapy followed by concomitant RT, cetuximab and cisplatin for inoperable HN-SCC
2011 ►
-
Modest Dominik P.; Brodowicz Thomas; Stintzing Sebastian; Jung Andreas; Neumann Jens; Laubender R. P.; Ocvirk Janja; Kurteva G.; Papai Z.; Knittelfelder R.; Kirchner Thomas; Heinemann V.; Zielinski Christoph C.
Impact of the specific mutation in KRAS codon 12 mutated tumors on treatment efficacy in patients with metastatic colorectal cancer receiving cetuximab-based first-line therapy
2012 ►
-
Velenik Vaneja; Ocvirk Janja; Oblak Irena; Anderluh Franc
Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial
2012 ►
-
Hu-Lieskovan Siwen; Bračko Matej; Velenik Vaneja
EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients
2011 ►
-
Ocvirk Janja
Management of cetuximab-induced skin toxicity with prophylactic use of topical vitamin K1 cream
2010 ►
-
Ocvirk Janja
Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial
2010 ►
-
Ocvirk Janja; Cencelj Simona
Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer
2010 ►
-
Velenik Vaneja; Ocvirk Janja; Oblak Irena; Anderluh Franc
A phase II study of cetuximab, capecitabine and radiotherapy in neoadjuvant treatment of patients with locally advanced resectable rectal cancer
2010 ►
-
Ocvirk Janja; Reberšek Martina
Management of cutaneous side effectsof cetuximab therapy with vitamin K1 creme
[Obvladovanje neželenih učinkov na kožo s kremo z vitaminom K1 pri bolnikih zdravljenih s cetuksimabom]
2008 ►
-
Ocvirk Janja; Reberšek Martina; Velenik Vaneja
Onkološko zdravljenje bolnikov z rakom debelega črevesa in danke
[Onkology treatment for patients with colon and rectal cancer]
2007 ►
-
Ocvirk Janja
Zdravljenje bolnikov z rakom debelega črevesa
[Treatment for patients with colon cancer]
2006 ►
Nova poizvedba
Pripombe
Na vrh strani
Inštitut za biostatistiko in medicinsko informatiko